“The compound SR-17018 is the primary biased agonist on the mu opioid receptor that does not result in tolerance with chronic use,” suggests Stahl, a senior staff members scientist from the Bohn lab. “It is a desirable feature for opportunity use from the context of Continual, serious pain.” Wow https://finnoktku.losblogos.com/34688262/details-fiction-and-sr-17018-legality